PNC Financial Services Group Inc. raised its position in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 21.5% in the fourth ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

President Trump said he would buy a Tesla, lifting shares of the EV maker. U.S. equities were mostly lower at midday as the ...

The 4% drop in the Nasdaq on Monday marked its worst day in years as Trump refused to rule out recession.

(NASDAQ:DXCM), the global leader in glucose biosensing, has announced the appointment of Renée Galá to its board of directors ...

Paycom Software (PAYC) shares advanced as KeyBanc upgraded the stock and raised the price target on optimism about sales, ...

Piper Sandler analyst Matthew O’Brien maintained a Buy rating on Dexcom (DXCM – Research Report) today and set a price target of $100.00. The ...

BofA keeps a Buy rating on DexCom (DXCM) with a $105 price target after Dexcom announced it received a warning letter from the FDA.

The FDA cited issues with DexCom’s response to prior inspection findings, known as Form 483 observations. The inspections took place at the San Diego facility between October 21 and November 7, 2024, ...

DexCom (NASDAQ:DXCM – Get Free Report) had its price target increased by equities researchers at Citigroup from $101.00 to ...

The S&P 500 advanced 1.1% on Wednesday, March 5, as the White House announced it would delay tariffs affecting U.S.